Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

501
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
501
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

603
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
603
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

552
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
552
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

633
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
633
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

299
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
299
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

649
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
649

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Remdesivir on Mortality in Mechanically Ventilated COVID-19 Patients: A Target Trial Emulation Using Inverse Probability of Treatment Weighting.

Infection and drug resistance·2026
Same author

Association between silymarin and age-related macular degeneration in patients with liver dysfunction: a nationwide cohort study.

Scientific reports·2026
Same author

Long-Term Cognitive Impairment After CAR-T Therapy Versus Autologous Stem Cell Transplantation: A Propensity Score-Matched Cohort Study.

Diagnostics (Basel, Switzerland)·2026
Same author

COVID-19 mRNA vaccination and immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a target trial emulation study.

Journal for immunotherapy of cancer·2026
Same author

Validation of the postnatal growth and retinopathy of prematurity criteria in Taiwanese: A prospective cohort study.

Pediatrics and neonatology·2026
Same author

The role of TRPV1 in corneal wound healing under a thyroxine-induced TAO-like condition.

Experimental eye research·2026

Related Experiment Video

Updated: Nov 17, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.4K

Association between Optic Neuritis and Inflammatory Bowel Disease: A Population-Based Study.

Yun-Hsiu Hsieh1, Chi-Hsiang Chung2,3,4, Chien-An Sun5,6

  • 1Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei City 11490, Taiwan.

Journal of Clinical Medicine
|February 13, 2021
PubMed
Summary

Patients with inflammatory bowel disease (IBD) face a higher risk of developing optic neuritis (ON). This risk is elevated in IBD patients aged 30-39 with specific comorbidities like neuromyelitis optica.

Keywords:
Crohn’s diseaseextraintestinal manifestationinflammatory bowel diseaseocular manifestationoptic neuritisulcerative colitis

More Related Videos

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
08:05

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Published on: March 1, 2017

9.5K
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.9K

Related Experiment Videos

Last Updated: Nov 17, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.4K
Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
08:05

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Published on: March 1, 2017

9.5K
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.9K

Area of Science:

  • Ophthalmology
  • Gastroenterology
  • Neurology

Background:

  • Inflammatory bowel disease (IBD) is frequently associated with extraintestinal manifestations.
  • Optic neuritis (ON) is a rare yet severe extraintestinal complication of IBD.

Purpose of the Study:

  • To investigate the risk factors associated with the development of optic neuritis (ON) in patients diagnosed with inflammatory bowel disease (IBD).

Main Methods:

  • A retrospective cohort study utilizing the Taiwan National Health Insurance Research Database (NHIRD) from 2000-2013.
  • Included adult IBD patients without prior ON, matched with a control group by age, sex, and index year.
  • Follow-up until ON diagnosis or study end, with statistical analysis of risk factors.

Main Results:

  • Patients with IBD showed a significantly higher incidence of ON (0.18%) compared to controls (0.003%, p=0.001).
  • Increased ON risk in IBD patients aged 30-39, with comorbidities such as neuromyelitis optica (NMO), acute disseminated encephalomyelitis (ADEM), and systemic lupus erythematosus (SLE).
  • Higher Charlson Comorbidity Index scores were also linked to increased ON risk.

Conclusions:

  • Inflammatory bowel disease (IBD) patients have an elevated risk of developing optic neuritis (ON).
  • ON incidence in IBD is particularly noted in the 30-39 age group and is associated with specific neurological and autoimmune comorbidities.
  • Factors beyond anti-tumor necrosis factor alpha (anti-TNFα) therapy appear more significantly linked to ON development in IBD patients.